Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021.
Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds.
Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience drug development to provide a precision medicine approach in clinical areas of high unmet need.
Contact us to learn more about our company and solutions.
Company Details
- Employees
- 8
- Address
- Block 1 – G28 Alderley Park, Congleton Road, Macclesfield,cheshire Sk10 4tg,united Kingdom
- in****@****ttx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- monumenttx.com
- Keywords
- neuroscience and drug development.
- HQ
- Macclesfield, Cheshire
Monument Therapeutics Questions
Monument Therapeutics's website is monumenttx.com
Monument Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/monumenttx
Monument Therapeutics has
8 employees.
View email and phone details for 8
employees at Monument Therapeutics.
Monument Therapeutics's industry is
Biotechnology Research
Monument Therapeutics's top competitors are
Ubiquigent Ltd,
Ignota Labs,
Cambridge Cognition,
Neurosterix,
Compass Pathways,
Shift Bioscience,
Nuvision Biotherapies Ltd,
Pencil Biosciences Limited,
Antiverse,
Talisman Therapeutics Limited.
Monument Therapeutics's support email address is info@monumenttx.com
Monument Therapeutics's categories are Biotechnology Research
